nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—ADRB1—obesity	0.204	0.543	CbGaD
Arformoterol—ADRB2—obesity	0.172	0.457	CbGaD
Arformoterol—ADRB2—Phenylpropanolamine—obesity	0.0913	0.216	CbGbCtD
Arformoterol—ADRB1—Phenylpropanolamine—obesity	0.0899	0.213	CbGbCtD
Arformoterol—CYP2A6—Bupropion—obesity	0.0649	0.154	CbGbCtD
Arformoterol—CYP2C9—Phentermine—obesity	0.0262	0.0622	CbGbCtD
Arformoterol—CYP2D6—Phentermine—obesity	0.024	0.0569	CbGbCtD
Arformoterol—CYP2C9—Bupropion—obesity	0.0223	0.0529	CbGbCtD
Arformoterol—CYP2D6—Bupropion—obesity	0.0204	0.0483	CbGbCtD
Arformoterol—CYP2C19—Cimetidine—obesity	0.0197	0.0467	CbGbCtD
Arformoterol—CYP2D6—Methamphetamine—obesity	0.0192	0.0455	CbGbCtD
Arformoterol—CYP2C9—Cimetidine—obesity	0.0164	0.0388	CbGbCtD
Arformoterol—CYP2D6—Cimetidine—obesity	0.015	0.0355	CbGbCtD
Arformoterol—CYP2C19—Topiramate—obesity	0.0129	0.0305	CbGbCtD
Arformoterol—Isoprenaline—PIK3R1—obesity	0.000726	0.143	CrCbGaD
Arformoterol—Fenoterol—ADRB3—obesity	0.000537	0.106	CrCbGaD
Arformoterol—Arbutamine—ADRB3—obesity	0.000503	0.0987	CrCbGaD
Arformoterol—Labetalol—ADRB3—obesity	0.000357	0.0701	CrCbGaD
Arformoterol—Dobutamine—COMT—obesity	0.000328	0.0645	CrCbGaD
Arformoterol—Isoprenaline—ADRB3—obesity	0.000262	0.0516	CrCbGaD
Arformoterol—Fenoterol—ADRB1—obesity	0.000243	0.0477	CrCbGaD
Arformoterol—Arbutamine—ADRB1—obesity	0.000227	0.0446	CrCbGaD
Arformoterol—Formoterol—ADRB1—obesity	0.000221	0.0433	CrCbGaD
Arformoterol—Dobutamine—ADRB1—obesity	0.000209	0.0411	CrCbGaD
Arformoterol—Ritodrine—ADRB2—obesity	0.000204	0.0401	CrCbGaD
Arformoterol—Fenoterol—ADRB2—obesity	0.000204	0.0401	CrCbGaD
Arformoterol—Arbutamine—ADRB2—obesity	0.000191	0.0375	CrCbGaD
Arformoterol—Formoterol—ADRB2—obesity	0.000186	0.0365	CrCbGaD
Arformoterol—Mediastinal disorder—Orlistat—obesity	0.000183	0.00138	CcSEcCtD
Arformoterol—Sleep disorder—Topiramate—obesity	0.000182	0.00137	CcSEcCtD
Arformoterol—Dizziness—Diethylpropion—obesity	0.000181	0.00137	CcSEcCtD
Arformoterol—Sinusitis—Bupropion—obesity	0.000179	0.00135	CcSEcCtD
Arformoterol—Diarrhoea—Cimetidine—obesity	0.000178	0.00135	CcSEcCtD
Arformoterol—Gastroenteritis—Topiramate—obesity	0.000178	0.00134	CcSEcCtD
Arformoterol—Mental disorder—Orlistat—obesity	0.000178	0.00134	CcSEcCtD
Arformoterol—Immune system disorder—Sibutramine—obesity	0.000177	0.00134	CcSEcCtD
Arformoterol—Malnutrition—Orlistat—obesity	0.000176	0.00133	CcSEcCtD
Arformoterol—Dobutamine—ADRB2—obesity	0.000176	0.0346	CrCbGaD
Arformoterol—Arrhythmia—Sibutramine—obesity	0.000175	0.00132	CcSEcCtD
Arformoterol—Vomiting—Diethylpropion—obesity	0.000174	0.00131	CcSEcCtD
Arformoterol—Nasal congestion—Topiramate—obesity	0.000173	0.0013	CcSEcCtD
Arformoterol—Rash—Diethylpropion—obesity	0.000173	0.0013	CcSEcCtD
Arformoterol—Dysgeusia—Orlistat—obesity	0.000173	0.0013	CcSEcCtD
Arformoterol—Dermatitis—Diethylpropion—obesity	0.000173	0.0013	CcSEcCtD
Arformoterol—Dizziness—Cimetidine—obesity	0.000172	0.0013	CcSEcCtD
Arformoterol—Headache—Diethylpropion—obesity	0.000172	0.00129	CcSEcCtD
Arformoterol—Rhinitis—Bupropion—obesity	0.000171	0.00129	CcSEcCtD
Arformoterol—Malnutrition—Sibutramine—obesity	0.000171	0.00129	CcSEcCtD
Arformoterol—Back pain—Orlistat—obesity	0.000171	0.00129	CcSEcCtD
Arformoterol—Pharyngitis—Bupropion—obesity	0.00017	0.00128	CcSEcCtD
Arformoterol—Muscle spasms—Orlistat—obesity	0.00017	0.00128	CcSEcCtD
Arformoterol—Urinary tract disorder—Bupropion—obesity	0.000169	0.00127	CcSEcCtD
Arformoterol—Oedema peripheral—Bupropion—obesity	0.000168	0.00127	CcSEcCtD
Arformoterol—Connective tissue disorder—Bupropion—obesity	0.000168	0.00127	CcSEcCtD
Arformoterol—Urethral disorder—Bupropion—obesity	0.000168	0.00126	CcSEcCtD
Arformoterol—Tension—Sibutramine—obesity	0.000168	0.00126	CcSEcCtD
Arformoterol—Dysgeusia—Sibutramine—obesity	0.000167	0.00126	CcSEcCtD
Arformoterol—Nervousness—Sibutramine—obesity	0.000166	0.00125	CcSEcCtD
Arformoterol—Vomiting—Cimetidine—obesity	0.000166	0.00125	CcSEcCtD
Arformoterol—Back pain—Sibutramine—obesity	0.000165	0.00125	CcSEcCtD
Arformoterol—Visual impairment—Bupropion—obesity	0.000165	0.00124	CcSEcCtD
Arformoterol—Rash—Cimetidine—obesity	0.000164	0.00124	CcSEcCtD
Arformoterol—Dermatitis—Cimetidine—obesity	0.000164	0.00124	CcSEcCtD
Arformoterol—Muscle spasms—Sibutramine—obesity	0.000164	0.00124	CcSEcCtD
Arformoterol—Ill-defined disorder—Orlistat—obesity	0.000164	0.00123	CcSEcCtD
Arformoterol—Headache—Cimetidine—obesity	0.000163	0.00123	CcSEcCtD
Arformoterol—Nausea—Diethylpropion—obesity	0.000163	0.00123	CcSEcCtD
Arformoterol—Hypoglycaemia—Topiramate—obesity	0.000161	0.00122	CcSEcCtD
Arformoterol—Labetalol—ADRB1—obesity	0.000161	0.0317	CrCbGaD
Arformoterol—Angioedema—Orlistat—obesity	0.000161	0.00122	CcSEcCtD
Arformoterol—Tremor—Sibutramine—obesity	0.00016	0.00121	CcSEcCtD
Arformoterol—Malaise—Orlistat—obesity	0.000159	0.0012	CcSEcCtD
Arformoterol—Cardiac disorder—Bupropion—obesity	0.000159	0.0012	CcSEcCtD
Arformoterol—Ill-defined disorder—Sibutramine—obesity	0.000158	0.00119	CcSEcCtD
Arformoterol—Agitation—Sibutramine—obesity	0.000157	0.00118	CcSEcCtD
Arformoterol—Angioedema—Sibutramine—obesity	0.000156	0.00118	CcSEcCtD
Arformoterol—Palpitations—Orlistat—obesity	0.000156	0.00118	CcSEcCtD
Arformoterol—Nausea—Cimetidine—obesity	0.000155	0.00117	CcSEcCtD
Arformoterol—Immune system disorder—Bupropion—obesity	0.000154	0.00116	CcSEcCtD
Arformoterol—Mediastinal disorder—Bupropion—obesity	0.000154	0.00116	CcSEcCtD
Arformoterol—Malaise—Sibutramine—obesity	0.000154	0.00116	CcSEcCtD
Arformoterol—Cough—Orlistat—obesity	0.000154	0.00116	CcSEcCtD
Arformoterol—Arrhythmia—Bupropion—obesity	0.000153	0.00115	CcSEcCtD
Arformoterol—Palpitations—Sibutramine—obesity	0.000151	0.00114	CcSEcCtD
Arformoterol—Chest pain—Orlistat—obesity	0.00015	0.00113	CcSEcCtD
Arformoterol—Myalgia—Orlistat—obesity	0.00015	0.00113	CcSEcCtD
Arformoterol—Mental disorder—Bupropion—obesity	0.00015	0.00113	CcSEcCtD
Arformoterol—Anxiety—Orlistat—obesity	0.00015	0.00113	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000149	0.00112	CcSEcCtD
Arformoterol—Cough—Sibutramine—obesity	0.000149	0.00112	CcSEcCtD
Arformoterol—Malnutrition—Bupropion—obesity	0.000149	0.00112	CcSEcCtD
Arformoterol—Discomfort—Orlistat—obesity	0.000148	0.00112	CcSEcCtD
Arformoterol—Hypertension—Sibutramine—obesity	0.000147	0.00111	CcSEcCtD
Arformoterol—Dry mouth—Orlistat—obesity	0.000147	0.00111	CcSEcCtD
Arformoterol—Dehydration—Topiramate—obesity	0.000146	0.0011	CcSEcCtD
Arformoterol—Tension—Bupropion—obesity	0.000146	0.0011	CcSEcCtD
Arformoterol—Dysgeusia—Bupropion—obesity	0.000146	0.0011	CcSEcCtD
Arformoterol—Myalgia—Sibutramine—obesity	0.000145	0.0011	CcSEcCtD
Arformoterol—Arthralgia—Sibutramine—obesity	0.000145	0.0011	CcSEcCtD
Arformoterol—Chest pain—Sibutramine—obesity	0.000145	0.0011	CcSEcCtD
Arformoterol—Anxiety—Sibutramine—obesity	0.000145	0.00109	CcSEcCtD
Arformoterol—Nervousness—Bupropion—obesity	0.000145	0.00109	CcSEcCtD
Arformoterol—Anaphylactic shock—Orlistat—obesity	0.000144	0.00109	CcSEcCtD
Arformoterol—Oedema—Orlistat—obesity	0.000144	0.00109	CcSEcCtD
Arformoterol—Back pain—Bupropion—obesity	0.000144	0.00109	CcSEcCtD
Arformoterol—Discomfort—Sibutramine—obesity	0.000144	0.00108	CcSEcCtD
Arformoterol—Hypokalaemia—Topiramate—obesity	0.000143	0.00108	CcSEcCtD
Arformoterol—Muscle spasms—Bupropion—obesity	0.000143	0.00108	CcSEcCtD
Arformoterol—Infection—Orlistat—obesity	0.000143	0.00108	CcSEcCtD
Arformoterol—Dry mouth—Sibutramine—obesity	0.000142	0.00107	CcSEcCtD
Arformoterol—Nervous system disorder—Orlistat—obesity	0.000141	0.00106	CcSEcCtD
Arformoterol—Nasopharyngitis—Topiramate—obesity	0.000141	0.00106	CcSEcCtD
Arformoterol—Skin disorder—Orlistat—obesity	0.00014	0.00105	CcSEcCtD
Arformoterol—Tremor—Bupropion—obesity	0.000139	0.00105	CcSEcCtD
Arformoterol—Gastritis—Topiramate—obesity	0.000139	0.00105	CcSEcCtD
Arformoterol—Oedema—Sibutramine—obesity	0.000139	0.00105	CcSEcCtD
Arformoterol—Anaphylactic shock—Sibutramine—obesity	0.000139	0.00105	CcSEcCtD
Arformoterol—Infection—Sibutramine—obesity	0.000138	0.00104	CcSEcCtD
Arformoterol—Ill-defined disorder—Bupropion—obesity	0.000138	0.00104	CcSEcCtD
Arformoterol—Agitation—Bupropion—obesity	0.000137	0.00103	CcSEcCtD
Arformoterol—Asthma—Topiramate—obesity	0.000136	0.00103	CcSEcCtD
Arformoterol—Angioedema—Bupropion—obesity	0.000136	0.00103	CcSEcCtD
Arformoterol—Tachycardia—Sibutramine—obesity	0.000136	0.00103	CcSEcCtD
Arformoterol—Labetalol—ADRB2—obesity	0.000136	0.0266	CrCbGaD
Arformoterol—Skin disorder—Sibutramine—obesity	0.000135	0.00102	CcSEcCtD
Arformoterol—Malaise—Bupropion—obesity	0.000134	0.00101	CcSEcCtD
Arformoterol—Angina pectoris—Topiramate—obesity	0.000133	0.001	CcSEcCtD
Arformoterol—Palpitations—Bupropion—obesity	0.000132	0.000992	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Orlistat—obesity	0.000131	0.000989	CcSEcCtD
Arformoterol—Bronchitis—Topiramate—obesity	0.000131	0.000987	CcSEcCtD
Arformoterol—Insomnia—Orlistat—obesity	0.00013	0.000982	CcSEcCtD
Arformoterol—Hypotension—Sibutramine—obesity	0.00013	0.000982	CcSEcCtD
Arformoterol—Cough—Bupropion—obesity	0.00013	0.00098	CcSEcCtD
Arformoterol—Hypertension—Bupropion—obesity	0.000128	0.000969	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Sibutramine—obesity	0.000127	0.000957	CcSEcCtD
Arformoterol—Dyspepsia—Orlistat—obesity	0.000127	0.000956	CcSEcCtD
Arformoterol—Myalgia—Bupropion—obesity	0.000127	0.000956	CcSEcCtD
Arformoterol—Arthralgia—Bupropion—obesity	0.000127	0.000956	CcSEcCtD
Arformoterol—Chest pain—Bupropion—obesity	0.000127	0.000956	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Topiramate—obesity	0.000126	0.000954	CcSEcCtD
Arformoterol—Anxiety—Bupropion—obesity	0.000126	0.000952	CcSEcCtD
Arformoterol—Insomnia—Sibutramine—obesity	0.000126	0.00095	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000126	0.000949	CcSEcCtD
Arformoterol—Discomfort—Bupropion—obesity	0.000125	0.000944	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Orlistat—obesity	0.000124	0.000937	CcSEcCtD
Arformoterol—Dyspnoea—Sibutramine—obesity	0.000124	0.000937	CcSEcCtD
Arformoterol—Fatigue—Orlistat—obesity	0.000124	0.000936	CcSEcCtD
Arformoterol—Dry mouth—Bupropion—obesity	0.000124	0.000935	CcSEcCtD
Arformoterol—Somnolence—Sibutramine—obesity	0.000124	0.000934	CcSEcCtD
Arformoterol—Pain—Orlistat—obesity	0.000123	0.000929	CcSEcCtD
Arformoterol—Hyperglycaemia—Topiramate—obesity	0.000123	0.000926	CcSEcCtD
Arformoterol—Dyspepsia—Sibutramine—obesity	0.000123	0.000925	CcSEcCtD
Arformoterol—Anaphylactic shock—Bupropion—obesity	0.000121	0.000916	CcSEcCtD
Arformoterol—Oedema—Bupropion—obesity	0.000121	0.000916	CcSEcCtD
Arformoterol—Infection—Bupropion—obesity	0.000121	0.00091	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Sibutramine—obesity	0.00012	0.000907	CcSEcCtD
Arformoterol—Constipation—Sibutramine—obesity	0.000119	0.000899	CcSEcCtD
Arformoterol—Pain—Sibutramine—obesity	0.000119	0.000899	CcSEcCtD
Arformoterol—Nervous system disorder—Bupropion—obesity	0.000119	0.000898	CcSEcCtD
Arformoterol—Isoprenaline—ADRB1—obesity	0.000119	0.0233	CrCbGaD
Arformoterol—Feeling abnormal—Orlistat—obesity	0.000119	0.000895	CcSEcCtD
Arformoterol—Tachycardia—Bupropion—obesity	0.000119	0.000894	CcSEcCtD
Arformoterol—Skin disorder—Bupropion—obesity	0.000118	0.00089	CcSEcCtD
Arformoterol—Urinary tract infection—Topiramate—obesity	0.000118	0.00089	CcSEcCtD
Arformoterol—Conjunctivitis—Topiramate—obesity	0.000118	0.00089	CcSEcCtD
Arformoterol—Gastrointestinal pain—Orlistat—obesity	0.000118	0.000888	CcSEcCtD
Arformoterol—Haematuria—Topiramate—obesity	0.000116	0.000873	CcSEcCtD
Arformoterol—Feeling abnormal—Sibutramine—obesity	0.000115	0.000866	CcSEcCtD
Arformoterol—Urticaria—Orlistat—obesity	0.000114	0.000863	CcSEcCtD
Arformoterol—Gastrointestinal pain—Sibutramine—obesity	0.000114	0.000859	CcSEcCtD
Arformoterol—Sinusitis—Topiramate—obesity	0.000114	0.000859	CcSEcCtD
Arformoterol—Abdominal pain—Orlistat—obesity	0.000114	0.000858	CcSEcCtD
Arformoterol—Body temperature increased—Orlistat—obesity	0.000114	0.000858	CcSEcCtD
Arformoterol—Hypotension—Bupropion—obesity	0.000114	0.000856	CcSEcCtD
Arformoterol—Urticaria—Sibutramine—obesity	0.000111	0.000835	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Bupropion—obesity	0.000111	0.000835	CcSEcCtD
Arformoterol—Abdominal pain—Sibutramine—obesity	0.00011	0.000831	CcSEcCtD
Arformoterol—Body temperature increased—Sibutramine—obesity	0.00011	0.000831	CcSEcCtD
Arformoterol—Insomnia—Bupropion—obesity	0.00011	0.000829	CcSEcCtD
Arformoterol—Rhinitis—Topiramate—obesity	0.000109	0.000824	CcSEcCtD
Arformoterol—Dyspnoea—Bupropion—obesity	0.000108	0.000817	CcSEcCtD
Arformoterol—Pharyngitis—Topiramate—obesity	0.000108	0.000815	CcSEcCtD
Arformoterol—Somnolence—Bupropion—obesity	0.000108	0.000814	CcSEcCtD
Arformoterol—Urinary tract disorder—Topiramate—obesity	0.000108	0.000811	CcSEcCtD
Arformoterol—Oedema peripheral—Topiramate—obesity	0.000107	0.000809	CcSEcCtD
Arformoterol—Connective tissue disorder—Topiramate—obesity	0.000107	0.000807	CcSEcCtD
Arformoterol—Dyspepsia—Bupropion—obesity	0.000107	0.000806	CcSEcCtD
Arformoterol—Urethral disorder—Topiramate—obesity	0.000107	0.000805	CcSEcCtD
Arformoterol—Hypersensitivity—Orlistat—obesity	0.000106	0.0008	CcSEcCtD
Arformoterol—Visual impairment—Topiramate—obesity	0.000105	0.000792	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Bupropion—obesity	0.000105	0.000791	CcSEcCtD
Arformoterol—Fatigue—Bupropion—obesity	0.000105	0.00079	CcSEcCtD
Arformoterol—Pain—Bupropion—obesity	0.000104	0.000783	CcSEcCtD
Arformoterol—Constipation—Bupropion—obesity	0.000104	0.000783	CcSEcCtD
Arformoterol—Asthenia—Orlistat—obesity	0.000103	0.000779	CcSEcCtD
Arformoterol—Hypersensitivity—Sibutramine—obesity	0.000103	0.000774	CcSEcCtD
Arformoterol—Pruritus—Orlistat—obesity	0.000102	0.000768	CcSEcCtD
Arformoterol—Cardiac disorder—Topiramate—obesity	0.000101	0.000762	CcSEcCtD
Arformoterol—Feeling abnormal—Bupropion—obesity	0.0001	0.000755	CcSEcCtD
Arformoterol—Asthenia—Sibutramine—obesity	0.0001	0.000754	CcSEcCtD
Arformoterol—Isoprenaline—ADRB2—obesity	9.98e-05	0.0196	CrCbGaD
Arformoterol—Gastrointestinal pain—Bupropion—obesity	9.93e-05	0.000749	CcSEcCtD
Arformoterol—Pruritus—Sibutramine—obesity	9.86e-05	0.000743	CcSEcCtD
Arformoterol—Diarrhoea—Orlistat—obesity	9.85e-05	0.000743	CcSEcCtD
Arformoterol—Immune system disorder—Topiramate—obesity	9.84e-05	0.000742	CcSEcCtD
Arformoterol—Mediastinal disorder—Topiramate—obesity	9.82e-05	0.00074	CcSEcCtD
Arformoterol—Urticaria—Bupropion—obesity	9.65e-05	0.000728	CcSEcCtD
Arformoterol—Body temperature increased—Bupropion—obesity	9.6e-05	0.000724	CcSEcCtD
Arformoterol—Abdominal pain—Bupropion—obesity	9.6e-05	0.000724	CcSEcCtD
Arformoterol—Mental disorder—Topiramate—obesity	9.54e-05	0.00072	CcSEcCtD
Arformoterol—Diarrhoea—Sibutramine—obesity	9.53e-05	0.000719	CcSEcCtD
Arformoterol—Dizziness—Orlistat—obesity	9.52e-05	0.000718	CcSEcCtD
Arformoterol—Malnutrition—Topiramate—obesity	9.48e-05	0.000715	CcSEcCtD
Arformoterol—Tension—Topiramate—obesity	9.3e-05	0.000702	CcSEcCtD
Arformoterol—Dysgeusia—Topiramate—obesity	9.29e-05	0.0007	CcSEcCtD
Arformoterol—Dizziness—Sibutramine—obesity	9.21e-05	0.000695	CcSEcCtD
Arformoterol—Nervousness—Topiramate—obesity	9.21e-05	0.000695	CcSEcCtD
Arformoterol—Back pain—Topiramate—obesity	9.17e-05	0.000692	CcSEcCtD
Arformoterol—Vomiting—Orlistat—obesity	9.15e-05	0.00069	CcSEcCtD
Arformoterol—Muscle spasms—Topiramate—obesity	9.12e-05	0.000688	CcSEcCtD
Arformoterol—Rash—Orlistat—obesity	9.08e-05	0.000685	CcSEcCtD
Arformoterol—Dermatitis—Orlistat—obesity	9.07e-05	0.000684	CcSEcCtD
Arformoterol—Headache—Orlistat—obesity	9.02e-05	0.00068	CcSEcCtD
Arformoterol—Hypersensitivity—Bupropion—obesity	8.95e-05	0.000675	CcSEcCtD
Arformoterol—Tremor—Topiramate—obesity	8.88e-05	0.00067	CcSEcCtD
Arformoterol—Vomiting—Sibutramine—obesity	8.86e-05	0.000668	CcSEcCtD
Arformoterol—Ill-defined disorder—Topiramate—obesity	8.8e-05	0.000664	CcSEcCtD
Arformoterol—Rash—Sibutramine—obesity	8.79e-05	0.000663	CcSEcCtD
Arformoterol—Dermatitis—Sibutramine—obesity	8.78e-05	0.000662	CcSEcCtD
Arformoterol—Headache—Sibutramine—obesity	8.73e-05	0.000658	CcSEcCtD
Arformoterol—Asthenia—Bupropion—obesity	8.72e-05	0.000657	CcSEcCtD
Arformoterol—Agitation—Topiramate—obesity	8.71e-05	0.000657	CcSEcCtD
Arformoterol—Pruritus—Bupropion—obesity	8.59e-05	0.000648	CcSEcCtD
Arformoterol—Nausea—Orlistat—obesity	8.55e-05	0.000645	CcSEcCtD
Arformoterol—Malaise—Topiramate—obesity	8.55e-05	0.000645	CcSEcCtD
Arformoterol—Palpitations—Topiramate—obesity	8.38e-05	0.000632	CcSEcCtD
Arformoterol—Diarrhoea—Bupropion—obesity	8.31e-05	0.000627	CcSEcCtD
Arformoterol—Nausea—Sibutramine—obesity	8.28e-05	0.000624	CcSEcCtD
Arformoterol—Cough—Topiramate—obesity	8.27e-05	0.000624	CcSEcCtD
Arformoterol—Hypertension—Topiramate—obesity	8.19e-05	0.000617	CcSEcCtD
Arformoterol—Chest pain—Topiramate—obesity	8.07e-05	0.000609	CcSEcCtD
Arformoterol—Arthralgia—Topiramate—obesity	8.07e-05	0.000609	CcSEcCtD
Arformoterol—Myalgia—Topiramate—obesity	8.07e-05	0.000609	CcSEcCtD
Arformoterol—Anxiety—Topiramate—obesity	8.04e-05	0.000607	CcSEcCtD
Arformoterol—Dizziness—Bupropion—obesity	8.03e-05	0.000606	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	8.02e-05	0.000605	CcSEcCtD
Arformoterol—Discomfort—Topiramate—obesity	7.98e-05	0.000602	CcSEcCtD
Arformoterol—Dry mouth—Topiramate—obesity	7.9e-05	0.000595	CcSEcCtD
Arformoterol—Oedema—Topiramate—obesity	7.74e-05	0.000584	CcSEcCtD
Arformoterol—Vomiting—Bupropion—obesity	7.72e-05	0.000582	CcSEcCtD
Arformoterol—Infection—Topiramate—obesity	7.69e-05	0.00058	CcSEcCtD
Arformoterol—Rash—Bupropion—obesity	7.66e-05	0.000578	CcSEcCtD
Arformoterol—Dermatitis—Bupropion—obesity	7.65e-05	0.000577	CcSEcCtD
Arformoterol—Headache—Bupropion—obesity	7.61e-05	0.000574	CcSEcCtD
Arformoterol—Nervous system disorder—Topiramate—obesity	7.59e-05	0.000572	CcSEcCtD
Arformoterol—Tachycardia—Topiramate—obesity	7.55e-05	0.00057	CcSEcCtD
Arformoterol—Skin disorder—Topiramate—obesity	7.52e-05	0.000567	CcSEcCtD
Arformoterol—Hypotension—Topiramate—obesity	7.23e-05	0.000545	CcSEcCtD
Arformoterol—Nausea—Bupropion—obesity	7.22e-05	0.000544	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Topiramate—obesity	7.05e-05	0.000532	CcSEcCtD
Arformoterol—Insomnia—Topiramate—obesity	7e-05	0.000528	CcSEcCtD
Arformoterol—Dyspnoea—Topiramate—obesity	6.9e-05	0.00052	CcSEcCtD
Arformoterol—Somnolence—Topiramate—obesity	6.88e-05	0.000519	CcSEcCtD
Arformoterol—Dyspepsia—Topiramate—obesity	6.81e-05	0.000514	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Topiramate—obesity	6.68e-05	0.000504	CcSEcCtD
Arformoterol—Fatigue—Topiramate—obesity	6.67e-05	0.000503	CcSEcCtD
Arformoterol—Pain—Topiramate—obesity	6.62e-05	0.000499	CcSEcCtD
Arformoterol—Constipation—Topiramate—obesity	6.62e-05	0.000499	CcSEcCtD
Arformoterol—Feeling abnormal—Topiramate—obesity	6.38e-05	0.000481	CcSEcCtD
Arformoterol—Gastrointestinal pain—Topiramate—obesity	6.33e-05	0.000477	CcSEcCtD
Arformoterol—Urticaria—Topiramate—obesity	6.15e-05	0.000464	CcSEcCtD
Arformoterol—Abdominal pain—Topiramate—obesity	6.12e-05	0.000461	CcSEcCtD
Arformoterol—Body temperature increased—Topiramate—obesity	6.12e-05	0.000461	CcSEcCtD
Arformoterol—Hypersensitivity—Topiramate—obesity	5.7e-05	0.00043	CcSEcCtD
Arformoterol—Asthenia—Topiramate—obesity	5.55e-05	0.000419	CcSEcCtD
Arformoterol—Pruritus—Topiramate—obesity	5.48e-05	0.000413	CcSEcCtD
Arformoterol—Diarrhoea—Topiramate—obesity	5.29e-05	0.000399	CcSEcCtD
Arformoterol—Dizziness—Topiramate—obesity	5.12e-05	0.000386	CcSEcCtD
Arformoterol—Vomiting—Topiramate—obesity	4.92e-05	0.000371	CcSEcCtD
Arformoterol—Rash—Topiramate—obesity	4.88e-05	0.000368	CcSEcCtD
Arformoterol—Dermatitis—Topiramate—obesity	4.87e-05	0.000368	CcSEcCtD
Arformoterol—Headache—Topiramate—obesity	4.85e-05	0.000366	CcSEcCtD
Arformoterol—Nausea—Topiramate—obesity	4.6e-05	0.000347	CcSEcCtD
Arformoterol—CYP2C9—Metabolism—NAMPT—obesity	5.88e-06	9.12e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOC3—obesity	5.86e-06	9.08e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—obesity	5.85e-06	9.06e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—LIPC—obesity	5.85e-06	9.06e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GCK—obesity	5.85e-06	9.06e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—obesity	5.84e-06	9.05e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOC3—obesity	5.81e-06	9e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MTHFR—obesity	5.78e-06	8.95e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—obesity	5.77e-06	8.94e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—obesity	5.77e-06	8.94e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—SREBF1—obesity	5.75e-06	8.91e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CETP—obesity	5.69e-06	8.82e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PPARA—obesity	5.67e-06	8.79e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PRKCD—obesity	5.66e-06	8.77e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CETP—obesity	5.64e-06	8.74e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—SDC1—obesity	5.63e-06	8.72e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GOT2—obesity	5.59e-06	8.67e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—SDC1—obesity	5.58e-06	8.64e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR2A—obesity	5.54e-06	8.58e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PRKCD—obesity	5.54e-06	8.58e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—AKR1C3—obesity	5.53e-06	8.58e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—C3—obesity	5.53e-06	8.57e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—obesity	5.52e-06	8.55e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—AGT—obesity	5.49e-06	8.51e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—AKR1C3—obesity	5.49e-06	8.5e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—FASN—obesity	5.47e-06	8.48e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—BCHE—obesity	5.45e-06	8.45e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—SCARB1—obesity	5.45e-06	8.44e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR2A—obesity	5.42e-06	8.4e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—C3—obesity	5.41e-06	8.38e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—SCARB1—obesity	5.4e-06	8.37e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—APOE—obesity	5.38e-06	8.34e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CAV1—obesity	5.33e-06	8.26e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	5.33e-06	8.26e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—APOA1—obesity	5.32e-06	8.24e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—SREBF1—obesity	5.29e-06	8.2e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IRS2—obesity	5.26e-06	8.15e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYP2E1—obesity	5.26e-06	8.15e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	5.26e-06	8.15e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AGT—obesity	5.25e-06	8.14e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—SREBF1—obesity	5.24e-06	8.13e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NQO1—obesity	5.2e-06	8.06e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—LEP—obesity	5.15e-06	7.98e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APOE—obesity	5.15e-06	7.98e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IRS2—obesity	5.15e-06	7.98e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GOT2—obesity	5.15e-06	7.97e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AGT—obesity	5.14e-06	7.97e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CAV1—obesity	5.1e-06	7.91e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GOT2—obesity	5.1e-06	7.91e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—obesity	5.09e-06	7.89e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APOA1—obesity	5.09e-06	7.89e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—obesity	5.05e-06	7.82e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APOE—obesity	5.04e-06	7.81e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LEP—obesity	5.04e-06	7.81e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—FASN—obesity	5.03e-06	7.8e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	5.03e-06	7.8e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—BCHE—obesity	5.01e-06	7.77e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—FASN—obesity	4.99e-06	7.74e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CAV1—obesity	4.99e-06	7.73e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—SLC2A4—obesity	4.99e-06	7.73e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GCG—obesity	4.99e-06	7.73e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APOA1—obesity	4.98e-06	7.72e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—BCHE—obesity	4.97e-06	7.7e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYCS—obesity	4.92e-06	7.63e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ESR1—obesity	4.92e-06	7.62e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PRKCB—obesity	4.86e-06	7.53e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—F2—obesity	4.86e-06	7.53e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3CG—obesity	4.85e-06	7.52e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYP2E1—obesity	4.84e-06	7.5e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GOT1—obesity	4.83e-06	7.48e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GGT1—obesity	4.83e-06	7.48e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ESR1—obesity	4.81e-06	7.45e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—BAD—obesity	4.8e-06	7.44e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYP2E1—obesity	4.8e-06	7.43e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NQO1—obesity	4.78e-06	7.41e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NCOA1—obesity	4.76e-06	7.37e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—F2—obesity	4.75e-06	7.36e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PRKCB—obesity	4.75e-06	7.36e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NQO1—obesity	4.74e-06	7.35e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—BAD—obesity	4.69e-06	7.27e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—STK11—obesity	4.69e-06	7.27e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYP19A1—obesity	4.69e-06	7.27e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PPARG—obesity	4.69e-06	7.26e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3CG—obesity	4.65e-06	7.2e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.64e-06	7.2e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—POMC—obesity	4.62e-06	7.16e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	4.6e-06	7.13e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—INS—obesity	4.6e-06	7.12e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IRS1—obesity	4.59e-06	7.12e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GCG—obesity	4.59e-06	7.11e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—SLC2A4—obesity	4.59e-06	7.11e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GCG—obesity	4.55e-06	7.05e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—SLC2A4—obesity	4.55e-06	7.05e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3CG—obesity	4.55e-06	7.04e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYCS—obesity	4.53e-06	7.01e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IRS1—obesity	4.49e-06	6.96e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYCS—obesity	4.49e-06	6.95e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GGT1—obesity	4.44e-06	6.88e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GOT1—obesity	4.44e-06	6.88e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—POMC—obesity	4.42e-06	6.86e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GOT1—obesity	4.4e-06	6.82e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GGT1—obesity	4.4e-06	6.82e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—INS—obesity	4.4e-06	6.82e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NCOA1—obesity	4.37e-06	6.78e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—COMT—obesity	4.36e-06	6.75e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NCOA1—obesity	4.34e-06	6.72e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCL2—obesity	4.33e-06	6.71e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—POMC—obesity	4.33e-06	6.71e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—STK11—obesity	4.31e-06	6.68e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYP19A1—obesity	4.31e-06	6.68e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—INS—obesity	4.3e-06	6.67e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PPARGC1A—obesity	4.3e-06	6.66e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GNB3—obesity	4.3e-06	6.66e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—HMOX1—obesity	4.28e-06	6.63e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYP19A1—obesity	4.27e-06	6.62e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—STK11—obesity	4.27e-06	6.62e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3CD—obesity	4.27e-06	6.61e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IGF1—obesity	4.25e-06	6.59e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AKT2—obesity	4.25e-06	6.59e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCL2—obesity	4.23e-06	6.56e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ALB—obesity	4.21e-06	6.53e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GNAS—obesity	4.18e-06	6.49e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IGF1—obesity	4.16e-06	6.45e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AKT2—obesity	4.16e-06	6.45e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOB—obesity	4.1e-06	6.35e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3CD—obesity	4.08e-06	6.33e-05	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	4.05e-06	6.27e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SERPINE1—obesity	4.04e-06	6.26e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3R1—obesity	4.03e-06	6.25e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—NOS3—obesity	4.03e-06	6.25e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—COMT—obesity	4.01e-06	6.21e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3CD—obesity	4e-06	6.19e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—COMT—obesity	3.97e-06	6.16e-05	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	3.96e-06	6.13e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GNB3—obesity	3.95e-06	6.13e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PPARGC1A—obesity	3.95e-06	6.13e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SERPINE1—obesity	3.95e-06	6.13e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—HMOX1—obesity	3.93e-06	6.1e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TYK2—obesity	3.93e-06	6.09e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PPARGC1A—obesity	3.92e-06	6.07e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GNB3—obesity	3.92e-06	6.07e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—LPL—obesity	3.91e-06	6.06e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—HMOX1—obesity	3.9e-06	6.05e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—RHOA—obesity	3.9e-06	6.04e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOS3—obesity	3.86e-06	5.98e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3R1—obesity	3.86e-06	5.98e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GNAS—obesity	3.85e-06	5.96e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TYK2—obesity	3.84e-06	5.96e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GPX1—obesity	3.82e-06	5.92e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GNAS—obesity	3.82e-06	5.91e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—RHOA—obesity	3.81e-06	5.91e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOS3—obesity	3.77e-06	5.85e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3R1—obesity	3.77e-06	5.85e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOB—obesity	3.77e-06	5.84e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOB—obesity	3.74e-06	5.79e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3CB—obesity	3.72e-06	5.77e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CD36—obesity	3.72e-06	5.76e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PTGS2—obesity	3.69e-06	5.71e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PIK3CA—obesity	3.67e-06	5.69e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—LPL—obesity	3.6e-06	5.58e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PIK3CA—obesity	3.59e-06	5.57e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—LPL—obesity	3.57e-06	5.53e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3CB—obesity	3.56e-06	5.52e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MTOR—obesity	3.56e-06	5.52e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MTHFR—obesity	3.52e-06	5.46e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GPX1—obesity	3.51e-06	5.44e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MTOR—obesity	3.48e-06	5.4e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3CB—obesity	3.48e-06	5.4e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GPX1—obesity	3.48e-06	5.39e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PPARA—obesity	3.46e-06	5.36e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CD36—obesity	3.42e-06	5.3e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CD36—obesity	3.39e-06	5.25e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—AGT—obesity	3.35e-06	5.19e-05	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—AKT1—obesity	3.31e-06	5.12e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOE—obesity	3.28e-06	5.08e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL6—obesity	3.25e-06	5.04e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CAV1—obesity	3.25e-06	5.04e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOA1—obesity	3.24e-06	5.02e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MTHFR—obesity	3.24e-06	5.02e-05	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—AKT1—obesity	3.23e-06	5.01e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MTHFR—obesity	3.21e-06	4.98e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL6—obesity	3.18e-06	4.93e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PPARA—obesity	3.18e-06	4.93e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PPARA—obesity	3.15e-06	4.88e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.1e-06	4.81e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MMP9—obesity	3.09e-06	4.8e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—AGT—obesity	3.08e-06	4.77e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—AGT—obesity	3.05e-06	4.73e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MMP9—obesity	3.03e-06	4.69e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOE—obesity	3.02e-06	4.68e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MAPK8—obesity	3.01e-06	4.66e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—AKT1—obesity	3e-06	4.65e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOE—obesity	2.99e-06	4.63e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CAV1—obesity	2.99e-06	4.63e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOA1—obesity	2.98e-06	4.62e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CAV1—obesity	2.96e-06	4.59e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3CG—obesity	2.96e-06	4.59e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOA1—obesity	2.96e-06	4.58e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MAPK8—obesity	2.94e-06	4.56e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—AKT1—obesity	2.94e-06	4.55e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PPARG—obesity	2.86e-06	4.43e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.83e-06	4.39e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—POMC—obesity	2.82e-06	4.37e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—INS—obesity	2.8e-06	4.34e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—STAT3—obesity	2.75e-06	4.26e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3CG—obesity	2.72e-06	4.22e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3CG—obesity	2.7e-06	4.18e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—STAT3—obesity	2.69e-06	4.17e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PPARG—obesity	2.63e-06	4.07e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PPARG—obesity	2.6e-06	4.04e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3CD—obesity	2.6e-06	4.03e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—POMC—obesity	2.59e-06	4.02e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—INS—obesity	2.58e-06	3.99e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—POMC—obesity	2.57e-06	3.98e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALB—obesity	2.57e-06	3.98e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MYC—obesity	2.56e-06	3.96e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—INS—obesity	2.55e-06	3.96e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TGFB1—obesity	2.55e-06	3.95e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MYC—obesity	2.5e-06	3.88e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TGFB1—obesity	2.49e-06	3.87e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3R1—obesity	2.46e-06	3.81e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NOS3—obesity	2.46e-06	3.81e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3CD—obesity	2.39e-06	3.71e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3CD—obesity	2.37e-06	3.68e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALB—obesity	2.36e-06	3.66e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALB—obesity	2.34e-06	3.63e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3CB—obesity	2.27e-06	3.51e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3CA—obesity	2.27e-06	3.51e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NOS3—obesity	2.26e-06	3.5e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3R1—obesity	2.26e-06	3.5e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PTGS2—obesity	2.25e-06	3.48e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3R1—obesity	2.24e-06	3.47e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NOS3—obesity	2.24e-06	3.47e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3CA—obesity	2.17e-06	3.36e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3CA—obesity	2.12e-06	3.29e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3CB—obesity	2.09e-06	3.23e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3CB—obesity	2.07e-06	3.2e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PTGS2—obesity	2.07e-06	3.2e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PTGS2—obesity	2.05e-06	3.18e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL6—obesity	1.92e-06	2.98e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL6—obesity	1.88e-06	2.91e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—AKT1—obesity	1.85e-06	2.87e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AKT1—obesity	1.77e-06	2.75e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AKT1—obesity	1.73e-06	2.69e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3CA—obesity	1.38e-06	2.14e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3CA—obesity	1.27e-06	1.97e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3CA—obesity	1.26e-06	1.95e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—AKT1—obesity	1.13e-06	1.75e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—AKT1—obesity	1.04e-06	1.61e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—AKT1—obesity	1.03e-06	1.6e-05	CbGpPWpGaD
